tocilizumab
roche,jw pharmaceuticals,roche
['lymsm', 'car-t', 'tocilizumab', 'lymphoma']
#eha2022 | pierre sesques, , addressed modifiable risk factors for toxicity and management of car-t toxicity in a real-world population. grade 3+ crs, icans, or tocilizumab and corticosteroids use did not have a negative impact on survival #lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm